Cerebral and cardiovascular diseases, such as stroke and heart failure, are high-risk and life-threatening.

There are cases in which patients are left with sequelae such as paralysis after the onset of the disease. On the other hand, it is known that early detection and treatment can reduce the risk of serious illness.

In some cases patients suffer effects after the onset of the disease, even paralysis.

Fortunately, early detection and treatment can reduce the risk of serious illness. The main causes of cerebral and cardiovascular diseases are hypertension and atrial fibrillation. Hypertension often progresses without symptoms. Atrial fibrillation, a type of arrhythmia, is also difficult to detect at an early stage because there are no symptoms or they quickly disappear.

OMRON Healthcare's blood pressure monitors and remote patient monitoring services support hypertension treatment and early detection of atrial fibrillation.

We are also accelerating the global development of electrocardiographs and smartphone applications for the early detection of atrial fibrillation and therapeutic intervention. We are also working on a new type of cardioverter-defibrillation monitoring system.

These projects strive toward our goal of “Going for ZERO.” This is our vision of a world with zero incidence (zero events) of cerebral and cardiovascular diseases.